Celosia Therapeutics

Macquarie Park, Australia · Founded 2022 · Privately Held (backing)

Developer of neurotherapeutic interventions designed for treatment-resistant neurodegenerative conditions. Celosia Therapeutics is based in Macquarie Park, Australia and was founded in 2022. It has raised $18.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$18.8M
Last round
—

Who backs Celosia Therapeutics?

4 investors
InvestorType
UniSuper Superannuation FundOther
Iomar Barrett—
Macquarie University Incubator—
Uniseed—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Celosia Therapeutics investors

4 investors are on record for Celosia Therapeutics, including UniSuper Superannuation Fund, Iomar Barrett, Macquarie University Incubator and Uniseed.

Free account
More of Celosia Therapeutics with a free account
  • ·Watch Celosia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Celosia Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View